i3 Analytics Announces Leadership Team
<0> LaVoie GroupDavid Connolly, 617-374-8800Vice President </0>
, a data analytics company providing deep insight into unstructured data and trends so pharmaceutical business development, clinical development, R&D, regulatory and clinical affairs teams can make fast, intelligent decisions, today announced its .
i3 Analytics, which offers the , web-based software that provides users with an easy to use map of biopharmaceutical landscape of data from scientific research, clinical trials and regulatory submissions, is led by , president and CEO; Archna Bhandari, vice president of data and analytics; Kirk Baker, vice president of technical development; and David Mir, vice president of strategy and business development.
“At i3 Analytics, we believe data analytics is for everybody,” said Zerhouni. “Our goal is to break down the walls of exclusivity that prevent universal access to data and to create usable platforms that allow everyone to access and understand biopharma data. This leads to better, faster and smarter decision-making.”
The i3 development team understands how to build connections between unstructured data from millions of documents. Members of the team played leading roles on the NIH dashboard project which led to the NIH Reporter. Since forming in 2011, i3 has worked exclusively on behalf of one of the world’s top-five pharmaceutical companies. Now the Biopharma Navigator, developed in partnership with that company, is available for small to mid-size biotech and pharmaceutical companies and other life science companies. By using natural language processing and extensive linking techniques, i3 provides deep insight into data and trends so business development, clinical development, R&D, regulatory and clinical affairs teams can make fast, intelligent decisions.
About the leadership team:
Zerhouni joined i3 Analytics with more than a decade of pharmaceutical and biopharmaceutical experience. In April 2005, Will became an associate at Covington & Burling and Kirkland & Ellis in Washington, D.C., where he focused on patent litigation for Hatch-Waxman cases on behalf of innovator pharmaceutical companies. Will also advised biopharmaceutical and health care companies on patent portfolios and evaluated the intellectual property of various growth stage companies. He also served as an assistant United States attorney for the Southern District of Florida. Zerhouni holds a B.A. in economics from Harvard University and is a graduate of Harvard Law School.
Bhandari has more than 20 years of experience in data analytics, knowledge representation, literature-based discovery and natural language processing and data visualization. A thought leader in new technology implementation, she sits at the intersection of research and innovation, applying her depth of knowledge and engineering experience to achieve breakthrough results. Prior to joining i3 Analytics, Archna was a senior manager at Attain, a professional services company that delivers solutions to public sector problems within government, health, higher education and academic medical centers. She earned an M.S. in computer science from Rochester Institute of Technology as well as a bachelor of engineering in chemical engineering from Birla Institute of Technology and Science.
Baker brings a unique skill set including expertise in theoretical algorithm development and implementation as well as expert programming ability to build practical, user-friendly software to meet the challenges of biopharmaceutical companies. He has an extensive background in natural language processing and statistical machine learning. In April 2010, Kirk became a senior consultant at Attain, where he led a research project in the National Institutes of Health's portfolio analysis group that focused on designing and implementing scalable, efficient knowledge discovery algorithms. He also served as a senior consultant and data analyst at Collexis Holdings, Inc. He earned his Ph.D. in computational linguistics at Ohio State University in 2008 and also has a master’s in linguistics from the University of North Carolina at Chapel Hill.
Mir has more than a decade of corporate strategy and commercial development experience in finance and health care. Prior to joining i3 Analytics, he worked in strategic transactions and business development at American Express, as a commercial development manager at Genworth Financial, and as senior manager of strategy and alliances at AOL. At Johns Hopkins Hospital, he was a senior financial project analyst. David has an MBA in finance from the Robert H. Smith School of Business and a B.A. in economics from Bucknell University.
Learn more about i3 Analytics data software from CEO Will Zerhouni here:
i3 Analytics is empowering biopharmaceutical companies and related industries to make fast, informed and intelligent decisions on business strategy, clinical affairs and product development. i3 Analytics’ flagship product is the Biopharma Navigator, analytics software that provides an intuitive map of the biopharma landscape. The Biopharma Navigator is a single entry point that provides access to focused search lenses, including the , , and . The company’s intuitive, accessible analytics tools navigate the complex world of data from scientific research, clinical trials and regulatory submissions in the US and Europe. i3 developed the Biopharma Navigator for a top-five, multi-national pharmaceutical company, and this product is now available to small and mid-size biotech and pharmaceutical companies. For more information, visit:
Photos/Multimedia Gallery Available: